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Anja Saalbach1
Fibroblasts provide matrix and regulatory mediators to the microenvironment and thereby contribute to
maintenance of tissue homeostasis, wound healing, and tumor progression. In the present study, we addressed
the functional relevance of Thy-1 for ﬁbroblast functions in vitro and in vivo. Using ﬁbroblasts from Thy-1− /− and
wild-type mice, recombinant expression of Thy-1, and analysis of the interaction of ﬁbroblasts with immobilized
Thy-1, we showed that Thy-1 has a crucial role in the control of cell growth by suppressing proliferation
and promoting apoptosis and differentiation of dermal ﬁbroblasts. Function-blocking studies revealed that
Thy-1 mediates the control of apoptosis and proliferation via modulation of β3 integrin function. Interestingly,
Thy-1-mediated growth control appears to be a more general mechanism because it also regulates growth of
tumor cells of different origin dependent on their β3 integrin expression. In summary, our ﬁndings point
to an important role of Thy-1 in controlling the balance between proliferation and differentiation in dermal
ﬁbroblasts.
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INTRODUCTION
Fibroblasts are the principal cellular components of con-
nective tissues found in most organs of the body. Main-
tenance of balance between ﬁbroblast proliferation and
differentiation is crucial for skin homeostasis (Varga and
Abraham, 2007; Eckes et al., 2014). Upon activation by skin
injury, dermal ﬁbroblasts migrate into damaged tissue, adhere
to provisional extracellular matrix, and proliferate (Singer and
Clark, 1999). Rearranging extracellular matrix structures,
mechanical tension, and the presence of transforming growth
factor-β (TGF-β) induce differentiation of ﬁbroblasts into fully
differentiated myoﬁbroblasts (Desmouliere et al., 1993;
Vaughan et al., 2000; Hinz, 2007). In physiological wound
repair, but not in tissue ﬁbrosis, myoﬁbroblasts are present
transiently and are removed by initiation of the apoptotic
machinery (Desmouliere et al., 1995). Therefore, dysregulation
of the balance between proliferation and myoﬁbroblast differ-
entiation results in abnormal wound healing and development
of ﬁbrotic diseases such as idiopathic pulmonary ﬁbrosis,
hypertrophic scars, or keloids (Gauglitz et al., 2011).
Thy-1 (CD90) is a glycosylphosphatidyl-anchored protein
of the immunoglobulin superfamily (Crawford and Barton,
1986). Originally, it was deﬁned as a murine T-cell marker
(Vitetta et al., 1973) but was later shown to be expressed on
activated microvascular endothelial cells (ECs), neurons,
hematopoietic stem cells, and ﬁbroblasts (Craig et al., 1993;
Saalbach et al., 1999). Different ligands/counterreceptors for
Thy-1 have been reported including β2, β3, β5 integrins, and
syndecan-4. Integrins interact via the integrin-binding RGD-
like motif (RLD) present in Thy-1 (Williams, 1989). Functional
studies in the neuronal system revealed that the interaction of
Thy-1 with αvβ3 and syndecan-4 induced formation of focal
adhesions and stress ﬁbers in astrocytes (Avalos et al., 2009).
Speciﬁcally, we described Thy-1 as an activation-associated
cell adhesion molecule on activated microvascular EC that
mediates adhesion and transendothelial migration of leuko-
cytes via interaction with the β2-leukocyte integrin Mac-1
(CD11b/CD18; Wetzel et al., 2004). Moreover, Thy-1
expressed on activated endothelium mediates binding to
αvβ3 integrin on melanoma cells, which facilitates melanoma
metastasis (Saalbach et al., 2002; Saalbach et al., 2005;
Schubert et al., 2013).
Several reports showed the involvement of Thy-1 in the
control of cell proliferation. Thy-1 was suggested to be a
negative growth regulator in Ras-transformed NIH 3T3 ﬁbro-
blasts (Sugimoto et al., 1991). In addition, diminished Thy-1
expression was detected in mouse lung ﬁbroblasts after
lipopolysaccharide-induced pulmonary ﬁbrosis, which is
characterized by excessive ﬁbroblast activation and prolifera-
tion (He et al., 2013). Furthermore, human lung ﬁbroblasts
derived from patients with hypersensitivity pneumonitis and
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idiopathic pulmonary ﬁbrosis (IPF) characterized by an
increased proliferative capacity are also Thy-1 negative
(Ramirez et al., 2011). In contrast, only a Thy-1-positive
subset of CD34+ human bone marrow hematopoietic stem
cells entered the cell cycle after cytokine stimulation, whereas
the Thy-1-negative subset remained quiescent (Takeda et al.,
2005). These data suggest different cell type- or context-
dependent functions for Thy-1. In contrast to multiple reports
on the functional role of Thy-1 to proliferation, only few
studies examined its contribution to apoptotic signaling (Rege
and Hagood, 2006).
In the present study, we show that lack of Thy-1 on dermal
ﬁbroblasts results in increased growth rates due to higher
proliferation rates and signiﬁcantly reduced apoptosis in a β3
integrin–dependent manner. In addition, we show that Thy-1
supports the differentiation of ﬁbroblasts to myoﬁbroblasts. Of
note, the growth control by Thy-1 was not restricted to
ﬁbroblasts but was also active in various tumor cell lines
dependent on their β3 integrin expression.
In summary, our ﬁndings indicate an important role of Thy-
1 on dermal ﬁbroblasts controlling the balance between
proliferation and apoptosis in a β3 integrin–dependent
manner.
RESULTS
Thy-1 controls growth of dermal ﬁbroblasts by downregulating
proliferation and stimulating apoptosis
To identify the physiological role of Thy-1 for ﬁbroblast
function dermal ﬁbroblasts from wild-type (wt) and Thy-1− /−
mice were analyzed. Crystal violet staining of ﬁbroblasts
obtained by outgrowth of skin explants revealed a higher cell
density and a more elongated and spindle-shaped morphol-
ogy of Thy-1− /− ﬁbroblast cultures after 72 hours compared
with controls (Figure 1a). By contrast, wt ﬁbroblasts were
more spread and rounder with large cytosolic stress ﬁbers and
distinct focal adhesions as identiﬁed by staining with
phalloidin and anti-vinculin antibody (Figure 1a). Because
of the differences in cell density and morphology of ﬁbroblasts
from Thy-1− /− and wt mice the functional role of Thy-1 for
the control of proliferation, differentiation, and apoptosis of
ﬁbroblasts was studied. Indeed, a lack of Thy-1 resulted in a
signiﬁcantly higher proliferation rate compared with wt
ﬁbroblasts measured by the incorporation of 5-bromo-2’-
deoxyuridine (BrdU) 24 hours after seeding the cells
(Figure 1b). Conversely, the number of apoptotic cells
assayed by detection of caspase 3/7 activity was decreased
in Thy-1− /− ﬁbroblasts after 3 and 4 days in culture
(Figure 1c). As a consequence of these differences in
proliferation and apoptosis, cell growth of dermal Thy-1− /−
ﬁbroblasts was signiﬁcantly increased compared with wt
ﬁbroblasts detected by metabolic conversion of the tetra-
zolium salt XTT (2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-
2H-tetrazolium-5-carboxanilide; Figure 1d). Fibroblasts
isolated by enzymatic digestion from different organs of wt
and Thy-1− /− mice displayed the same differences in cell
growth (Supplementary Figure S1 online), indicating that
Thy-1-mediated growth control is not restricted to dermal
ﬁbroblasts. To conﬁrm the effect of Thy-1 on cell growth,
HT1080 cells (human ﬁbrosarcoma cell line), which lack
Thy-1 expression, were stably transfected with human Thy-1
complementary DNA, and the impact on cell proliferation,
apoptosis, and cell growth was studied (Figure 1e–g).
Re-expression of Thy-1 in HT1080 cells (Supplementary
Figure S2 online) signiﬁcantly reduced their proliferation rates
compared with vector-transfected cells (Figure 1e) and
resulted in enhanced numbers of apoptotic cells detected by
staining of active caspases 3/7 (Figure 1f). Consequently,
re-expression of Thy-1 massively decreased cell growth of
HT1080 ﬁbrosarcoma cells (Figure 1g).
Thy-1 supports ﬁbroblast differentiation
Next, the role of Thy-1 on differentiation of dermal ﬁbroblasts
was investigated. As shown in Figure 2a, Thy-1− /− ﬁbroblasts
showed a signiﬁcantly reduced capacity to contract freely
ﬂoating collagen lattices compared with wt ﬁbroblasts after
24 hours, indicating decreased contractive forces of Thy-1− /−
ﬁbroblasts. Furthermore, quantitative real-time reverse-tran-
scriptase–PCR revealed downregulation in Thy-1− /− ﬁbro-
blasts of TGF-β and of the most reliable myoﬁbroblast-speciﬁc
markers including αSMA, ﬁbronectin, and its splice variant
ED-A FN, as well as collagen I(α1) and collagen III(α1)
72 hours after seeding the cells (Figure 2b). Accordingly, the
release of biologically active TGF-β detected by the mink-lung
epithelial cell-mediated chemiluminescence (Abe et al.,
1994) (Figure 2c) and the expression of αSMA detected by
western blot (Figure 2d) were clearly decreased in Thy-1− /−
compared with wt ﬁbroblasts 72 hours after seeding the cells.
Moreover, immunoﬂuorescence staining of αSMA and F-actin
in wt ﬁbroblasts displayed a clear organization of αSMA into
stress ﬁbers, one morphological characteristic of differentiated
myoﬁbroblasts (Tomasek et al., 2002). In contrast, in Thy-1− /−
ﬁbroblasts, αSMA showed a diffuse expression within the cell
with rare incorporation of αSMA into stress ﬁbers (Figure 2e).
Taken together, Thy-1 seems to be crucially involved in the
differentiation of dermal ﬁbroblasts.
Thy-1 controls proliferation and apoptosis by modulation of β3
integrin function
Next, cell growth of Thy-1− /− ﬁbroblasts seeded for 72 hours
on immobilized, recombinant Thy-1 coupled to an IgG Fc
(rThy-1 (RLD)-Fc) was analyzed. Indeed, interaction of
Thy-1− /− ﬁbroblasts with immobilized rThy-1 (RLD)-Fc
signiﬁcantly decreased cell growth compared with cells
grown on a Fc-coupled control protein (Fc control protein)
(Figure 3a). In contrast, wt ﬁbroblasts were not affected by
rThy-1 (RLD)-Fc. Interestingly, immobilization of Thy-1 seems
to be important, as addition of soluble Thy-1 did not inﬂuence
cell growth of Thy-1− /− ﬁbroblasts (Figure 3a). Seeding Thy-1-
negative ﬁbroblasts on physiologic β3 integrin ligand,
vitronectin, did not affect cell growth, indicating speciﬁcity
of Thy-1-mediated growth restriction (Supplementary Figure
S3 online). Moreover, rThy-1 (RLD)-Fc promoted differentia-
tion of Thy-1− /− ﬁbroblasts. As shown in Figure 3b, interac-
tion of Thy-1− /− ﬁbroblasts with immobilized rThy-1 (RLD)-Fc
signiﬁcantly increased mRNA expression levels of the
myoﬁbroblast markers αSMA and ED-A FN, as well as the
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extracellular matrix protein collagen I(α1) after 72 hours. In
parallel, secretion of bioactive TGF-β, one of the most
important inducers of myoﬁbroblast differentiation, was
increased in Thy-1− /− ﬁbroblasts after 72 hours (Figure 3c).
Function-blocking studies revealed that blocking β3 integrins
by anti-CD61 monoclonal antibody (mAb) for 72 hours
reversed the reduction in cell growth by immobilized rThy-1
(RLD)-Fc (Figure 3d). In contrast, blocking the β1 integrin
chain by anti-CD29 mAb in Thy-1− /− ﬁbroblasts had no effect
on cell growth. Detailed studies revealed that blocking of β3
integrins partially enhanced proliferation (Figure 3e) but fully
abrogated Thy-1-induced apoptosis (Figure 3f). Inhibition of
interaction between cell-associated Thy-1 and β3 integrin by
function-blocking antibody resulted in a decrease in cell
growth in wt ﬁbroblasts (Supplementary Figure S4 online),
clarifying the physiologic importance of Thy-1/β3 integrin
interaction.
Thy-1 controls proliferation, apoptosis, and differentiation of
ﬁbroblasts in healing skin wounds in vivo
First, healthy skin and full-thickness wounds at day 7 were
analyzed to show expression of Thy-1 and its counter receptor
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Figure 1. Thy-1 determines cell morphology and controls cell growth by downregulation of proliferation and stimulation of apoptosis. (a) Representative
images show differences in cell density and morphology of crystal violet stained wt and Thy-1− /− ﬁbroblasts grown on tissue culture plastic for 72 hours. Original
magniﬁcation ×10, scale bar indicates 100 μm. F-actin containing stress ﬁbers were stained with Alexa 488–conjugated phalloidin, and focal adhesions were
stained with anti-vinculin antibody in wt and Thy-1− /− ﬁbroblasts grown on tissue culture plastic for 72 hours. Cell nuclei were counterstained with DAPI.
Original magniﬁcation ×40, scale bar indicates 50 μm. (b) Cell proliferation after 24 hours detected by BrdU incorporation, (c) apoptosis determined by
caspase 3/7 activation, and (d) cell growth measured by XTT in wt and Thy-1− /− skin ﬁbroblasts (n⩾6 animals per genotype). (e and f) Human ﬁbrosarcoma
cells HT1080 were transfected with Thy-1 cDNA, and differences in (e) cell proliferation, (f) apoptosis, and (g) cell growth were determined compared
with the vector control (n⩾ 3 independent experiments). Data are given as mean± SD **P⩽0.01; ***P⩽ 0.001. BrdU, 5-bromo-2’-deoxyuridine; RLU, relative
light unit; wt, wild type; XTT, 2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide.
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β3 integrin (CD61; Figure 4a). Interestingly, in healthy skin, β3
integrin (CD61) was only barely detectable, whereas strong β3
integrin expression was observed in wounds. β3 integrin–
positive and Thy-1-positive cells were located in the same
region of the wound;thus, they could potentially interact with
each other. Furthermore, merged images show Thy-1/β3
integrin double-positive cells (Figure 4a). To conﬁrm a co-
expression of β3 integrin and Thy-1, we isolated cells from
wound tissue by enzymatic digestion and demonstrated by
ﬂow cytometric analysis that Thy-1 and β3 integrin are
expressed on the same cell (Figure 4b). As activated ECs
express Thy-1, ECs were excluded from the analysis by CD31
staining. To identify the cells expressing β3 integrin and Thy-1
double staining of intracellular collagen type I and β3 integrin
or Thy-1 was performed in cells of wound tissue. Flow
cytometric analysis revealed that both β3 integrin and Thy-1
are expressed on collagen I–expressing cells (Figure 4c),
indicating that Thy-1 and β3 integrin are expressed on
ﬁbroblasts during wound healing.
To assess whether Thy-1 exerts anti-proliferative and pro-
differentiation functions in vivo, proliferation, differentiation,
and apoptosis were studied in the granulation tissue of full-
thickness wounds of Thy-1− /− mice and wt controls. In
parallel to our in vitro results, cell proliferation in the
granulation tissue of Thy-1− /− mice was increased at 7 days
post wounding detected by immunoﬂuorescence staining of
Ki67 as a proliferation marker (Figure 4d and e). These
ﬁndings were supported by signiﬁcantly increased prolifera-
tion rates of ﬁbroblasts enzymatically isolated from wounds of
Thy-1− /− versus wt mice (Figure 4f). By contrast, we observed
by trend more apoptotic cells in wounds of wt mice compared
with wounds of Thy-1− /− mice (Figure 4g). In parallel,
transcript levels of myoﬁbroblast-speciﬁc differentiation mar-
kers αSMA, ED-A FN, and of collagen III(α1) were signiﬁcantly
decreased in wounds of Thy-1− /− mice (Figure 4h). Immu-
nostaining of collagen III(α1) in wounds of Thy-1− /− and wt
mice conﬁrmed these data (Figure 4i), again paralleling the
in vitro ﬁndings (Figure 2). Taken together, Thy-1 is involved
in controlling the balance between proliferation and differ-
entiation of dermal ﬁbroblasts during tissue restoration
following injury in vivo by downregulating proliferation and
stimulating differentiation and apoptosis.
Thy-1 controls proliferation and apoptosis of tumor cells via
interaction with β3 integrins
We next asked whether the control of proliferation by Thy-1 is
restricted to ﬁbroblasts or represents a more general mechan-
ism. As various tumor cells express β3 integrin, cell growth of
human and mouse tumor cells plated on rThy-1 (RLD)-Fc was
assessed after 72 hours. Expression of β3 integrin on the
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dermal ﬁbroblasts, which were grown for 72 hours. αSMA is organized in F-actin containing stress ﬁbers (merge). Original magniﬁcation × 20, scale bar
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indicated tumor cells is summarized in Supplementary Table
S1 online. In fact, rThy-1 (RLD)-Fc was able to suppress cell
growth of tumor cell lines from different origins, depending on
their β3 integrin expression (Figure 5a). Thus, rThy-1 (RLD)-Fc
signiﬁcantly inhibited cell growth of β3-expressing melanoma
(JPC, MeWo), prostate adenocarcinoma (PC-3), ﬁbrosarcoma
(HT1080), and mouse hepatocellular carcinoma (Hep534)
cell lines. In contrast, cell growth of all β3-negative tumor
cells including melanoma cell line Bro, hepatocellular
carcinoma cells HepG2, the breast cancer cells Py2T, and
EpH4, as well as the colon carcinoma cell line CT-26, was
completely independent of Thy-1. Taken together, Thy-1/β3
integrin interaction is required for Thy-1-mediated cell growth
regulation. Further, functional studies using β3 integrin–
positive ﬁbrosarcoma cells HT1080 showed that, consistent
with results from ﬁbroblasts, blocking β3 integrin by function-
blocking antibodies for 72 hours reversed the Thy-1-induced
growth suppression (Figure 5b). As shown in Figure 5c/d,
blocking β3 integrin partially reversed Thy-1-mediated
suppression of proliferation and completely abolished
Thy-1-mediated induction of apoptosis.
Taken together, Thy-1 controls growth of tumor cells by
suppression of proliferation and induction of apoptosis via
interaction with β3 integrin on tumor cells.
DISCUSSION
Fibroblasts are the most important cells for the production,
degradation, and re-organization of the extracellular matrix
and thus in providing the tissue microenvironment. Therefore,
maintaining the balance between cell proliferation, apoptosis,
and differentiation of ﬁbroblasts is crucial for tissue home-
ostasis, physiological wound healing/scar formation, preven-
tion of tissue ﬁbrosis, and of tumor progression. Previously,
we described Thy-1 as an activation-induced cell–cell
adhesion molecule on microvascular ECs mediating the
binding and transmigration of myeloid cells as well as tumor
cells and thus having a role in the control of inﬂammation
(Schubert et al., 2011) and tumor metastasis (Schubert et al.,
2013). In contrast to ECs, Thy-1 is highly and constitutively
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expressed at the cell surface of ﬁbroblasts. In the present
study, we addressed the functional relevance of Thy-1 for
ﬁbroblast functions in vitro and in vivo using Thy-1-deﬁcient
and wild-type mice. Numerous factors including growth
factors, growth factor receptors, cytokines, and matrix
components have been described to stimulate cell prolifera-
tion (Yoneda et al., 1988; Somasundaram and Schuppan,
1996; Strutz et al., 2001; Zhang et al., 2004), whereas the
list of factors known to limit proliferation is much shorter.
Remarkably, we demonstrate that Thy-1 has a crucial role in
the regulation of cell growth by suppressing proliferation and
promoting apoptosis and differentiation of dermal ﬁbroblasts
and is thereby critical for maintaining the balance between
ﬁbroblast proliferation and differentiation.
Several studies reported a signiﬁcantly enhanced prolifera-
tive response of Thy-1− /− lung ﬁbroblasts to different mitogens
using rat lung Thy-1+/+ and Thy-1− /− ﬁbroblast subpopula-
tions (Hagood et al., 1999; Hagood et al., 2001). Moreover, in
idiopathic pulmonary ﬁbrosis, ﬁbroblastic foci representing
proliferating ﬁbroblasts are predominantly Thy-1− /− (Zhou
et al., 2004; Hagood et al., 2005). Here, we show that Thy-1
limits the basal proliferation of dermal ﬁbroblasts without
Figure 4. Thy-1 controls proliferation, apoptosis, and differentiation during wound healing through the interaction with β3 integrins. (a) Expression of Thy-1
(green) and β3 integrin (red) by immunoﬂuorescence staining in healthy skin and full-thickness wounds at day 7. Cell nuclei were counterstained with DAPI
(blue). White arrows marked double-positive cells in merged images. Original magniﬁcation × 20, scale bar indicates 100 μm. (b) Flow cytometric analysis of
freshly isolated cells from wound tissue by enzymatic digestion. CD61 and Thy-1 are expressed on the same cell type in 7-day-old wounds of wt mouse.
Endothelial cells were excluded from cell count by CD31 staining. (c) Double staining of intracellular collagen type I with CD61 or Thy-1 indicates that Thy-1 and
CD61 are expressed on ﬁbroblasts during wound healing. (d) Immunoﬂuorescence staining of Ki-67 (left panel: original magniﬁcation × 4; right panel original
magniﬁcation ×40) indicating proliferating cells (green) in 7-day-old wound sections from wt and Thy-1− /− mice. Granulation tissue was counterstained with
anti-αSMA antibody (red), and cell nuclei were stained with DAPI (blue). Scale bar indicates 200 μm (left panel) and 50 μm (right panel). Representative pictures of
n= 14 animals per genotype are shown. (e) Number of Ki67-positive cells in granulation tissue of wounds from wt and Thy-1− /− mice (n=14 animals per
genotype). (f) Proliferation of wound ﬁbroblasts isolated from 7-day-old wounds of wt and Thy-1− /− mice (n=5 animals per genotype). (g) Amount of apoptotic
cells in granulation tissue of 7-day-old wounds of wt and Thy-1− /− mice (n⩾7 animals per genotype). (h) mRNA expression of myoﬁbroblast-speciﬁc αSMA, ED-
A FN, and the extracellular matrix protein collagen III in 7-day-old wounds of wt and Thy-1− /−mice (n= 18 animals per genotype). (i) Deposition of collagen type
III in 7-day-old wounds of wt and Thy-1− /− mice. Representative pictures of n=14 animals per genotype are shown. Original magniﬁcation x10, scale bar
indicates 100 μm. Data are given as mean± SD. **P⩽0.01; ***P⩽0.001. BrdU, 5-bromo-2’-deoxyuridine; hf, hair follicle; he, hyperproliferative epidermis;
gt, granulation tissue; RLU, relative light unit; we, wound edge; wt, wild type.
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Figure 5. Growth control of tumor cells by rThy-1 (RLD)-Fc is mediated by β3 integrin. (a) Cell growth of different tumor cell lines seeded on immobilized
rThy-1 (RLD)-Fc after 72 hours (n=4 experiments). (b) HT1080 cells were incubated for 72 hours with αvβ3 integrin–inhibitory antibody, seeded on rThy-1 (RLD)-
Fc, and the effect on (b) cell growth, (c) cell proliferation, and (d) apoptosis was analyzed (n⩾ 3 experiments). Data are given as mean± SD. *P⩽ 0.05;
**P⩽0.01; ***P⩽0.001. BrdU, 5-bromo-2’-deoxyuridine; hf, hair follicle; RLD, RGD-like motif; RLU, relative light unit; wt, wild type.
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addition of any further mitogenic stimulus. Consistently, re-
expression of Thy-1 suppressed cell proliferation. In addition,
increased proliferation of ﬁbroblasts in healing wounds of Thy-
1-deﬁcient mice compared with wild-type mice conﬁrmed the
importance of Thy-1 for the control of proliferation in vivo. In
accordance, Lee et al. (2013) described increased proliferation
rates in Thy-1 siRNA–treated NIH3T3 cells.
As the balance between proliferation and cell death is
important for tissue homeostasis, the impact of Thy-1 for the
control of apoptosis was analyzed. We found that lack of Thy-
1 or blocking Thy-1/β3 integrin interactions in skin ﬁbroblasts
resulted in reduced apoptosis. In accordance, during wound
healing, the number of apoptotic cells were lower in Thy-1-
deﬁcient than in control mice.
Concerning Thy-1-mediated control of ﬁbroblast differen-
tiation, several studies analyzing Thy-1+/+ and Thy-1− /−
ﬁbroblast subpopulations isolated from rat lungs described
Thy-1− /− ﬁbroblasts as proﬁbrotic cells (McIntosh et al.,
1994). In contrast, our data reveal that expression of Thy-1
maintains a differentiated phenotype reﬂected by enhanced
spreading, higher expression of typical myoﬁbroblast markers,
and augmented contractile forces. In contrast to Hagood and
Zhou who studied lung ﬁbroblasts (Zhou et al., 2004; Hagood
et al., 2005), we used dermal ﬁbroblasts of Thy-1-deﬁcient
and wt mice without any further ﬁbrogenic stimulation.
Moreover, these ﬁbroblasts differ exclusively in Thy-1
expression. Different tissue origin and species might explain
the conﬂicting results as DNA microarray studies clearly
revealed different gene expression proﬁles in ﬁbroblasts from
different anatomical sites of the human body (Rinn et al.,
2006), demonstrating heterogeneous ﬁbroblast phenotypes
across different organs. However, we were able to show Thy-
1-mediated restriction of cell growth in ﬁbroblasts obtained
from other tissues including heart, kidney, and lung.
Furthermore, we show using integrin-blocking antibodies
that the interaction of Thy-1 with β3 integrins but not β1
integrins is necessary for suppression of proliferation and
induction of apoptosis in dermal ﬁbroblasts. However,
blocking of β3 integrins did not completely reverse Thy-1-
mediated suppression of proliferation, suggesting that Thy-1
may interact with additional ligands to accomplish these
effects. Recent studies described the proteoglycan syndecan-4
as a counter receptor for Thy-1 that—in cooperation with
αvβ3 integrin—promotes astrocyte migration and the forma-
tion of focal adhesions and stress ﬁbers (Avalos et al., 2009;
Kong et al., 2013). The involvement of syndecan-4 in the Thy-
1-mediated control of proliferation awaits conﬁrmation by
future studies. In contrast to the effects on proliferation,
blocking of β3 integrins completely abrogated Thy-1-induced
apoptosis of ﬁbroblasts, indicating that the control of
apoptosis by Thy-1 is exclusively mediated by β3 integrins.
Taken together, our data suggest that Thy-1 limits ﬁbroblast
growth by restriction of proliferation in combination with
stimulation of differentiation and apoptosis. Moreover, β3
integrin–dependent suppression of cell growth by recombi-
nant Thy-1 indicates that Thy-1 acts in trans by engagement of
β3 integrins on neighbouring cells. Currently, it is unknown
whether Thy-1 might act with β3 integrins on the same cell. In
addition, further studies have to clarify whether Thy-1
functions as an agonist for β3 integrins or as an antagonist
preventing the binding of natural β3 integrin ligands. Thus,
Thy-1 might be a structural component of cell–cell contacts in
ﬁbroblasts involved in density sensing that contribute to
contact inhibition in a physiological setting. Unexpectedly, in
light of the important role of Thy-1 in the regulation of
proliferation, apoptosis, and differentiation, Thy-1-deﬁcient
mice displayed no spontaneous phenotype such as ﬁbrosis or
ﬁbroblast hyperproliferation. This may be explained by our
ﬁnding that healthy murine skin does not express β3 integrins.
Co-expression of Thy-1 and β3 integrins was only observed in
the granulation tissue in 7-day-old wounds, where differences
in cell proliferation, apoptosis, and production of extracellular
matrix proteins in Thy-1− /− mice and wt mice were indeed
detected.
Finally, analysis of cell growth, proliferation, and apoptosis
of different tumor cells upon interaction with rThy-1 demon-
strated that Thy-1/β3 integrin–mediated cell growth control is
not restricted to ﬁbroblasts. Although many reports link β3
integrin expression to tumor progression (Desgrosellier and
Cheresh, 2010), we show that interaction of Thy-1 with β3
integrins reduced proliferation and triggered cell death in
various tumor cells, depending on β3 integrin expression on
the tumor cells. This is supported by the observation that the
levels of β3 integrin expression in glioma and hepatocellular
carcinoma correlate with sensitivity to apoptosis induction and
colony formation (Wu et al., 2009; Kim et al., 2011). In
agreement with our results from integrin-blocking studies in
Thy-1− /− dermal ﬁbroblasts blocking αvβ3 integrin in HT1080
cells partially reversed Thy-1-mediated inhibition of prolifera-
tion and completely abolished Thy-1-mediated induction of
apoptosis. We postulate that expression of Thy-1 on ﬁbroblasts
might be one mechanism to limit cell proliferation.
Taken together, our ﬁndings demonstrate an important role
for the interaction of Thy-1 expressed at the surface of
ﬁbroblasts with β3 integrins on adjacent cells including
ﬁbroblasts or tumor cells in controlling the balance between
proliferation, apoptosis, and differentiation. This interaction
might thus have a critical role in tissue repair, tumor
progression, and ﬁbrosis.
MATERIALS AND METHODS
Mice
Thy-1-deﬁcient (Thy-1− /−) mice were a kind gift from Dr R. Morris
(King’s College London). Thy-1− /− mice had been established on a
129/Sv×C57BL/6 background as described previously (Nosten-
Bertrand et al., 1996). The mice were backcrossed to C57/BL6
background eleven times. F2 littermates from the intercross of F1
Thy-1+/− mice were used for comparative studies between Thy-1− /−
and wt mice. Mice were provided with food and water ad libitum and
kept under a 12-hour light–dark cycle. All animal experiments were
in accordance with institutional and state guidelines and approved
by the Committee on Animal Welfare of Saxony (TVV 05/11).
Isolation of murine primary ﬁbroblasts and cell culture
Primary skin ﬁbroblasts of Thy-1− /− and wt mice were isolated by
outgrowth from skin biopsies. Fibroblasts were cultured in DMEM
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(Biochrom AG, Berlin, Germany) supplemented with 10% fetal calf
serum (Biochrom) and 1% ZellShield (Minerva Biolabs, Berlin,
Germany) at 37 °C and 5% CO2. Human and mouse tumor cell lines
were cultured in indicated media (Supplementary Table 1). 5 μg ml− 1
rec. Thy-1 (RLD)-Fc in coating buffer containing 0.2 M Na2CO3 and
0.2 M NaHCO3, (pH9.5) was immobilized on NUNC Maxisorb plates
(Nunc, Roskilde, Denmark) overnight at 4 °C. Plates were blocked
with DMEM containing 5% fetal calf serum. Cells were seeded at a
density of 5× 103 cells per well in the presence or absence of
5 μgml−1 function-blocking antibodies or isotype controls.
Functional assays
Cell proliferation was quantiﬁed by BrdU incorporation according to
the manufacturer´s protocol using the BrdU-Cell Proliferation ELISA
(Roche, Mannheim, Germany). The chemiluminescence signal was
detected using a BioTek Synergy HT microplate reader (BioTek
Instruments, Winooski, VT).
The activity of caspase 3/7 was measured using the Caspase-Glo
3/7 Assay (Promega, Madison, WI) according to the manufacturer’s
protocol. The luminescence signal was detected at indicated time
points using a microplate reader (BioTek Instruments). To exclude
differences in caspase 3/7 activity due to different proliferation rates,
the luminescent signal was expressed per 1× 104 cells.
Cell growth analysis was performed by the XTT salt assay (Roche).
Absorbance at 490 nm was measured 2 hours after addition of XTT
using a microplate reader (BioTek Instruments, Bad Friedrichshall,
Germany).
Collagen gel contraction assay
2.5×105 ﬁbroblasts were seeded into freely ﬂoating collagen gels con-
taining 1mgml−1 collagen type I from rat tail tendons (BD, Heidelberg,
Germany) and incubated at 37 °C and 5% CO2 for 24 hours. The gel
area in mm2 was calculated using Adope Photoshop version CS5.
Generation of Thy-1-transfected HT1080 cells
HT1080 cells were transfected with a pcDNA-vector or vector
containing full-length Thy-1 complementary DNA (Saalbach et al.,
2005) using Lipofectamine LTX Reagent (Invitrogen, OR) according
to the manufacturer´s instructions. Blasticidin (Invitrogen) was added
to select stably transfected cells.
RNA preparation and quantitative real-time reverse-
transcriptase–PCR
Total RNA was extracted using the Qiagen RNeasy Mini Kit (Qiagen,
Hilden, Germany). 1 μg total RNA was used for ﬁrst strand comple-
mentary DNA synthesis with M-MLV reverse transcriptase (Promega,
Madison, WI) according to the manufacturer´s protocol. quantitative
real-time reverse-transcriptase–PCR was performed with GoTaq
qPCR MasterMix (Promega) in a RotorGene RG-3000 (Corbett Life
Sciences, Sydney, Australia). Primer sequences (Metabion, Martinsried,
Germany) are summarized in Supplementary Table S2 online.
Immunoblotting
Cells were lysed with RIPA-buffer (25 mM Tris (pH 8), 150mM NaCl,
2 mM EDTA, 1% NP40 (w/v), and proteinase inhibitor cocktail
cOmplete (Roche). After separation of proteins by SDS-PAGE and
blotting to OPTITRAN BA-S83 membranes (Whatman GmbH,
Dassel, Germany), proteins were detected with appropriate primary
and secondary antibodies (Supplementary Material and Methods
online) and subsequent scanning with a LI-COR Odyssey imager
(LI-COR Biosciences, Nebraska, NE). Band densities were quantiﬁed
using Odyssey analytical software version 3.0 (LI-COR Biosciences).
TGF-β bioassay
Bioactive TGF-β was determined using mink-lung epithelial cells
(Abe et al., 1994). The chemiluminescence signal was expressed per
1× 104 cells.
Wound healing model
Full-thickness (including panniculus carnosus) wounds were
inﬂicted under anesthesia with 6mm dermal biopsy punches on
both sites on the shaved backs of 10–12-week-old wt and Thy-1− /−
mice as described (Blumbach et al., 2010). At indicated time points,
mice were killed and wounds without adjacent margins were quick-
frozen for western blot analysis or stored in RNAlater solution
(Ambion, Darmstadt, Germany) for RNA preparation. Wounds with
adjacent margin were embedded in TissueTek compound for
cryosectioning.
Isolation of wound ﬁbroblasts with Liberase DL
Fibroblasts were isolated from different organs of wt and Thy-1− /−
mice or wound tissue harvested at 7 days after injury by enzymatic
digestion using 26 Uml− 1 of Liberase DL (Roche) for 2 hours at 37 °C
and 5%CO2. For subsequent ﬂow cytometric analysis, cells were
washed twice and ﬁltered using cell strainer (40 μm).
Immunoﬂuorescence analysis
Cryosections of 6 μm were stained with primary antibodies or isotype
controls diluted in PBS, 0.1% Tween 20, 3% bovine serum albumin,
and appropriate secondary antibodies (Supplementary Material and
Methods online). Washing steps were performed with PBS, 0.1%
Tween 20. Labeling of DNA strand breaks for detection of apoptotic
cells was performed using the In Situ Cell Death Detection Kit
(Roche) according to the manufacturer´s protocol. Cell nuclei were
counterstained with DAPI (Merck, Darmstadt, Germany). Immuno-
ﬂuorescence images were photographed with a BZ-9000Z micro-
scope (Keyence, Neu-Isenburg, Germany). The number of labeled
cells in the granulation tissue detected by αSMA staining was
calculated with corresponding Keyence analyzer software version
2.2 (Keyence).
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